Rise in demand for personalized medicine, government funding for omics, increase in pharmaceutical & biotechnology R&D expenditure, and surge in applications of RNA sequencing have boosted the growth of the global transcriptomics market. The market across Asia-Pacific is anticipated to showcase the highest CAGR of 8.7% during the forecast period. The Covid-19 pandemic had a positive impact on the market due to increase in production of vaccines and rise in investment to study immune response in Covid-19 infected patients.
Rise in demand for personalized medicine, government funding for omics, increase in pharmaceutical & biotechnology R&D expenditure, and surge in applications of RNA sequencing have boosted the growth of the global transcriptomics market. The market across Asia-Pacific is anticipated to showcase the highest CAGR of 8.7% during the forecast period. The Covid-19 pandemic had a positive impact on the market due to increase in production of vaccines and rise in investment to study immune response in Covid-19 infected patients.